In the latest trading session,, 1.12 million Boston Scientific Corp (NYSE:BSX) shares changed hands as the company’s beta touched 0.68. With the company’s most recent per share price at $106.73 changed hands at -$0.68 or -0.63% at last look, the market valuation stands at $157.90B. BSX’s current price is a discount, trading about -0.75% off its 52-week high of $107.53. The share price had its 52-week low at $71.88, which suggests the last value was 32.65% up since then. When we look at Boston Scientific Corp’s average trading volume, we note the 10-day average is 7.95 million shares, with the 3-month average coming to 8.35 million.
Analysts gave the Boston Scientific Corp (BSX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.34. If we narrow down to specifics, the data shows that 0 out of 15 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 1 recommended BSX as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight.
Boston Scientific Corp (NYSE:BSX) trade information
Instantly BSX was in red as seen in intraday trades today. With action 2.51%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 38.61%, with the 5-day performance at 2.51% in the green. However, in the 30-day time frame, Boston Scientific Corp (NYSE:BSX) is 1.40% up. Looking at the short shares, we see there were 17.49 million shares sold at short interest cover period of 2.28 days.
The consensus price target for the stock as assigned by Wall Street analysts is 117.5, meaning bulls need an upside of 9.17% from its recent market value. According to analyst projections, BSX’s forecast low is 100 with 130 as the target high. To hit the forecast high, the stock’s price needs a -21.8% plunge from its current level, while the stock would need to tank 6.31% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -17.84%. The 2025 estimates are for Boston Scientific Corp earnings to increase by 16.31%, but the outlook for the next 5-year period is at 14.06% per year.
BSX Dividends
Boston Scientific Corp is expected to release its next quarterly earnings report on 2025-Apr-23.
Boston Scientific Corp (NYSE:BSX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.18% of Boston Scientific Corp shares while 93.22% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 93.39%. There are 93.22% institutions holding the Boston Scientific Corp stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 9.6192% of the shares, roughly 141.46 million BSX shares worth $10.89 billion.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 8.8311% or 129.87 million shares worth $10.0 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . With 46.63 shares estimated at $4.96 billion under it, the former controlled 3.15% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard 500 Index Fund held about 2.77% of the shares, roughly 40.95 shares worth around $4.36 billion.
